4.5 Article

Global estimates of undiagnosed diabetes in adults

Journal

DIABETES RESEARCH AND CLINICAL PRACTICE
Volume 103, Issue 2, Pages 150-160

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.diabres.2013.11.001

Keywords

Undiagnosed diabetes; Prevalence; Type 2 diabetes; Epidemiology; Health systems

Funding

  1. Lilly Diabetes
  2. Merck and Co, Inc.
  3. Novo Nordisk A/S
  4. Novo Nordisk Changing Diabetes(R) initiative
  5. Pfizer, Inc.
  6. Sanofi Diabetes

Ask authors/readers for more resources

Aims: The prevalence of diabetes is rapidly increasing worldwide. Type 2 diabetes may remain undetected for many years, leading to severe complications and healthcare costs. This paper provides estimates of the prevalence of undiagnosed diabetes mellitus (UDM), using available data from high quality representative population-based sources. Methods: Data sources reporting both diagnosed and previously undiagnosed diabetes were identified and selected according to previously described IDF methodology for diabetes in adults (aged 20-79). Countries were divided into 15 data regions based on their geographic IDF Region and World Bank income classification. The median UDM proportion was calculated from selected data sources for each of data region. The number of UDM cases in 2013 was calculated from country, age and sex-specific estimates of known diabetes cases and data region-specific UDM proportion. Results: Of 744 reviewed data sources, 88 sources representing 74 countries had sufficient information and were selected for generation of estimates of UDM. Globally, 45.8%, or 174.8 million of all diabetes cases in adults are estimated to be undiagnosed, ranging from 24.1% to 75.1% across data regions. An estimated 83.8% of all cases of UDM are in low- and middle-income countries. At a country level, Pacific Island nations have the highest prevalence of UDM. Conclusions: There is a high proportion of UDM globally, and especially in developing countries. Further high-quality studies of UDM are needed to strengthen future estimates. (C) 2013 Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available